Introduction
Postural Orthostatic Tachycardia Syndrome (POTS), a condition of the autonomic nervous system (ANS), is one type of dysautonomia; where there is a considerable increase in heart rate when standing, but without a significant reduction in blood pressure.1 A medical imaging technology, known as an electrocardiogram (ECG), helps rule out other diagnoses and helps us identify the POTS diagnosis.2 Though no ECG pattern is definitive for POTS, several anomalies may be present and can guide clinical suspicion.3 This page covers POT's key electrocardiographic characteristics, diagnosis assessment, and treatment, as well as other aspects.
Overview
POTS mostly strikes biological women between the ages of 15 and 50.4 The condition is thought to afflict 1 to 3 million Americans annually.1 Within 10 minutes of standing or tilting the head forward, the clinical phenomenon known as POTS occurs, with an increase in heart rate of at least 30 beats per minute (bpm), and in the case of teenagers, 40 bpm. People often have great functional restrictions, and the syndrome can be devastating.5,6
Causes and pathophysiology
- Low blood sugar content: Many times, patients have lowered blood volume, which stimulates sympathetic activity to sustain brain perfusion when standing7
- Autonomic Failure: Compromised autonomic control, specifically sympathetic hyperactivity and parasympathetic withdrawal, produces an exaggerated heart rate response and inadequate vasoconstriction (the tightening of blood vessels to reduce blood flow to certain areas)3
- Hyperadrenergic state of mind: For some people, standing up increases norepinephrine levels, which rapidly increases heart rate as part of the “fight or flight” response to stress
- System of Immune Protection: Sometimes the relationship between autoantibodies targeting nervous system-related receptors suggests a probable autoimmune component6
- COVID-19 and Post-Viral Illness: Increasing numbers of cases have been linked to viral infections, particularly SARS-CoV-2, which produce "long COVID" syndromes4
Signs and symptoms
POTS has a broad spectrum of symptoms and can compromise several separate systems. Common examples consist of:1,4
- Cardiovascular: Palpitations, lightheadedness, chest discomfort, and near syncope (Fainting)
- Neurological: Headaches, tiredness, and cognitive impairment
- Gastric: Nausea, distension (swelling), and constipation
- Peripheral: Mottled skin, cold extremities
- Functional: Intolerance of exercise, anxiety, and depression
Findings in POTS
Though POTS is mostly a clinical diagnosis, the initial evaluation depends on the ECG to rule out structural heart disease.2,5
Although a single ECG pattern cannot provide a conclusive identification for POTS, numerous electrocardiographic scans provide a clearer diagnosis, and look out for the following abnormalities:
Sinus' tachycardia
The most typically occurring ECG sign, the heart rate quickly rises, often above 100-130 bpm, when standing. POTS patients often have normal ECGs when at rest but tachycardia is clearly seen when they stand up or do an orthostatic test.1,9
Standard Structural Indicators
Typical POTS does not reveal any structural anomalies, including ST elevation, ventricular hypertrophy, or bundle branch blockings. These could indicate either alternate or concurrent cardiac disease.3,10
Treatment of POTS
POTS is handled individually and from a multidisciplinary perspective. The objectives include symptom alleviation and restoring functionality.
Non-medical strategies
To keep hydrated, sip two to three litres of fluids daily, and unless otherwise stated, three to five grams of sodium daily may help. Wearing compression clothing also helps to lessen venous pooling.
Exercises such as rowing and cycling, which are seated, can help with cardiovascular conditioning and prevent any significant changes in heart rate or blood pressure from posture.
Stress management and cognitive-behavioral therapy are behavioural approaches for anxiety and depression that may also arise.4,5,6
Medications
- Beta-blockers: Low doses of propranolol could help to reduce tachycardia
- Ivabradine: Inhibits the sinus node without changing blood pressure
- Fludrocortisone: Increases blood volume to counteract pressure changes
- Midodrine: An alpha-agonist meant to cause vasoconstriction
- Pyridostigmine: Raises parasympathetic reactions6,9
Naturally, any medications should be taken at the advice of a medical professional
Summary
Postural Orthostatic Tachycardia Syndrome is a complicated autonomic control condition that seriously reduces quality of life and affects young women most of all.The ECG is a fundamental first test to rule out potentially fatal cardiac causes of tachycardia. Furthermore supporting evidence include indications of autonomic regulation or sinus tachycardia. Diagnosis is much influenced by the orthostatic heart rate response as well as clinical factors. Management is difficult as it must combine lifestyle choices with prescription drugs catered to the person’s needs. As our knowledge of POTS, especially concerning post-viral diseases like prolonged COVID, advances, the use of basic but effective methods like ECG in clinical evaluation keeps increasing.
FAQs
Is POTS a form of heart disease?
No, POTS is an autonomic nervous system disorder, not a primary heart disease, although it affects heart rate.
Can POTS be seen on an ECG?
ECG may show sinus tachycardia, but it is mainly used to rule out other causes of symptoms.
Is POTS a permanent condition?
In many cases, especially post-viral POTS, symptoms can improve or resolve with time and treatment.
Can POTS cause fainting?
Yes, although more commonly it causes near-fainting due to cerebral hypoperfusion upon standing.
Is POTS related to anxiety?
While symptoms may mimic anxiety, POTS is a physiological disorder. However, anxiety may co-exist or be exacerbated by symptoms.
What is the role of ivabradine in POTS?
Ivabradine lowers heart rate by acting on the sinus node and can reduce symptoms in patients with tachycardia.
Does exercise help with POTS?
Yes, structured recumbent exercise is a cornerstone of non-drug management and can improve autonomic tone.
Can dehydration worsen POTS symptoms?
Yes, adequate hydration is essential in minimizing symptoms.
Is POTS hereditary?
There may be a genetic predisposition, but POTS is not strictly inherited in most cases.
Can POTS occur after COVID-19?
Yes, POTS is increasingly recognized in long COVID patients, often termed post-acute sequelae of SARS-CoV-2 infection.
References
- Raj SR. Postural tachycardia syndrome(Pots). Circulation. 2013;127(23): 2336–2342. https://doi.org/10.1161/CIRCULATIONAHA.112.144501. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.112.144501
- Naegeli B, Straumann E, Gerber A, Schuiki E, Kunz M, Niederhäuser U, et al. Dual chamber pacing with a single‐lead ddd pacing system. Pacing and Clinical Electrophysiology. 1999;22(7): 1013–1019. https://doi.org/10.1111/j.1540-8159.1999.tb00565.x. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1540-8159.1999.tb00565.x
- Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clinical Autonomic Research. 2011;21(2): 69–72. https://doi.org/10.1007/s10286-011-0119-5. Available from: https://link.springer.com/article/10.1007/s10286-011-0119-5
- Sheldon RS, Grubb BP, Olshansky B, Shen WK, Calkins H, Brignole M, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6): e41–e63. https://doi.org/10.1016/j.hrthm.2015.03.029. Available from: https://www.heartrhythmjournal.com/article/S1547-5271(15)00328-8/fulltext
- Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. Journal of Internal Medicine. 2019;285(4): 352–366. https://doi.org/10.1111/joim.12852. Available from: https://onlinelibrary.wiley.com/doi/10.1111/joim.12852
- Benarroch EE. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clinic Proceedings. 2012;87(12): 1214–1225. https://doi.org/10.1016/j.mayocp.2012.08.013. Available from: https://www.mayoclinicproceedings.org/article/S0025-6196(12)00896-8/fulltext
- Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. International Journal of Medical Sciences. 2010; 62–67. https://doi.org/10.7150/ijms.7.62. Available from: https://www.medsci.org/v07p0062.htm
- Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, et al. Postural orthostatic tachycardia syndrome: the mayo clinic experience. Mayo Clinic Proceedings. 2007;82(3): 308–313. https://doi.org/10.4065/82.3.308. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0025619611610276
- Raj SR, Robertson D. Blood volume perturbations in the postural tachycardia syndrome. The American Journal of the Medical Sciences. 2007;334(1): 57–60. https://doi.org/10.1097/MAJ.0b013e318063c6c0. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002962915325374
- Low PA, Sandroni P, Joyner M, Shen W. Postural tachycardia syndrome(Pots). Journal of Cardiovascular Electrophysiology. 2009;20(3): 352–358. https://doi.org/10.1111/j.1540-8167.2008.01407.x. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1540-8167.2008.01407.x

